Video

NSCLC Molecular Testing Recommendations for Community Hospitals

Recommendations for community hospitals and physicians on the critically necessary molecular tests needed for patients with NSCLC.

Related Videos
Nicolas Girard, MD
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Shirish M. Gadgeel, MD
Jacob Sands, MD
Real world evidence of treatment practices and therapeutic outcomes for newly diagnosed NSCLC patients with non-classical EGFR mutations demonstrates high unmet medical need
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3 Positive Tumors: Patients with LCNEC
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Charu Aggarwal, MD, MPH, FASCO